VTVT - vTv Therapeutics Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/2015
Total Revenue291634519
Cost of Revenue---
Gross Profit291634519
Operating Expenses
Research Development39,64045,74829,584
Selling General and Administrative11,3339,9069,077
Non Recurring---
Others---
Total Operating Expenses---
Operating Income or Loss-50,682-55,020-38,142
Income from Continuing Operations
Total Other Income/Expenses Net-7365-1,190
Earnings Before Interest and Taxes-50,755-54,955-39,332
Interest Expense3,0923981,775
Income Before Tax-53,847-55,353-41,107
Income Tax Expense800--
Minority Interest---
Net Income From Continuing Ops-16,144-16,352-27,498
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-16,144-16,352-27,498
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-16,144-16,352-27,498